Azzad Asset Management Inc /Adv Invitae Corp Transaction History

Azzad Asset Management Inc /Adv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Apr 01, 2024	SELL	$2.13 - $9.01 $26,650 - $112,733	-12,512 Closed	0 $0
Q1 2022 Apr 01, 2024	BUY	$6.28 - $15.59 $6,933 - $17,211	1,104 Added 9.68%	12,512 $99.7 Million
Q4 2021 Apr 01, 2024	BUY	$14.7 - $28.67 $7,879 - $15,367	536 Added 4.93%	11,408 $174 Million
Q3 2021 Apr 01, 2024	BUY	$24.31 - $33.6 $58,076 - $80,270	2,389 Added 28.16%	10,872 $309 Million
Q2 2021 Apr 01, 2024	BUY	$26.09 - $40.4 $29,507 - $45,692	1,131 Added 15.38%	8,483 $286 Million

Q1 2021 Apr 01, 2024	BUY	$33.06 - $56.93 $243,057 - $418,549	7,352 New	7,352 $281 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.